icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
PVRtGdmpeEe9Ywwq